Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;30(2):125-133.
doi: 10.1293/tox.2017-0006. Epub 2017 Feb 11.

A brief review of kidney development, maturation, developmental abnormalities, and drug toxicity: juvenile animal relevancy

Affiliations
Review

A brief review of kidney development, maturation, developmental abnormalities, and drug toxicity: juvenile animal relevancy

John Curtis Seely. J Toxicol Pathol. 2017 Apr.

Abstract

Nonclinical juvenile animal tests perform a valuable role in determining adverse drug effects during periods of organogenesis and/or functional maturation. Developmental anatomic and functional maturation time points are important to consider between juveniles and adults when regarding different organ toxicities in response to drug administration. The kidney is an example of a major organ that has differences in these time points in comparing juveniles to adults and in contrasting humans to laboratory animal species. Toxicologic pathologists, involved in juvenile studies, need to be aware of these time points which are age-related exposure periods of sensitivity to drug toxicity. Age-related developmental anatomic and functional maturation are factors which can affect the way that a drug is absorbed, distributed, metabolized, and excreted (ADME). Changes to any component of ADME may alter drug toxicity resulting in kidney abnormalities, nephrotoxicity, or maturational disorders. Juvenile animal kidneys may either be less resistant or more resistant to known adult nephrotoxic drug effects. Furthermore, drug toxicity observed in juvenile animal kidneys may not always correspond to similar toxicities in humans. Juvenile animal nonclinical toxicology studies targeting the kidneys have to be carefully planned to attain the maximum knowledge from each study.

Keywords: abnormalities; development; juvenile animals; kidney; maturation; toxicity.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Schematic of kidney development representing the pronephros (A), mesonephros (B), and metanephros (C). Modified from Patten and Saxén (schematic courtesy of David Sabio).
Fig. 2.
Fig. 2.
Nephrogenesis – Reciprocol Induction. The four initial steps of mesenchymal-to-epithelial transformation (MET) dependent on the close interaction of metanephric mesenchyme (MM) and the urinary bud (UB).
Fig. 3.
Fig. 3.
Schematic representation of nephrogenesis illustrating the configurational changes as nephrons develop. Modified from Saxén, Cho and Dressler, Dressler, and McMahon (schematic courtesy of David Sabio).
Fig. 4.
Fig. 4.
Histological appearance of postnatal day 11 rat kidney. Most glomeruli, particularly in the outer cortex, are immature appearing. Tubules are not fully mature.

References

    1. Beck MJ, Padgett EL, Bowman CJ, Wilson DT, Kaufman LE, Varsho BJ, Stump DG, Nemec MD, and Holson JF. Nonclinical juvenile toxicity testing. In: Developmental and Reproductive Toxicology, 2nd ed. RD Hood (ed). Taylor and Francis, Boca Raton. 263–327. 2006.
    1. Food and Drug Administration (FDA) Guidance for Industry Nonclinical Safety Evaluation of Pediatric Drug Products. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); Rockville. 2006.
    1. Osterberg RE. FDA Approach to pediatric testing. In: Pediatric Non-clinical Drug Testing: Principles, Requirements, and Practices. AM Hoberman, and EM Lewis (eds). John Wiley & Sons, Inc., Hoboken. 59–77. 2012.
    1. Lewis EM, De Schaepdrijver LM, and Coogan TP. Introduction. In: Pediatric Non-clinical Drug Testing: Principles, Requirements, and Practices. AM Hoberman, and EM Lewis (eds). John Wiley & Sons, Inc., Hoboken. 1–27. 2012.
    1. Bruckner JV. Differences in sensitivity of children and adults to chemical toxicity: the NAS panel report. Regul Toxicol Pharmacol. 31: 280–285. 2000. - PubMed

LinkOut - more resources